The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Sophocarpidine-Global Market Insights and Sales Trends 2025
Synopsis
Sophocarpidine (CAS：519-02-8) is a white acicular crystal or crystalline powder with bitter taste. It is the main raw material for the production of oxymatrine and widely used in the treatment of liver diseases.
The global Sophocarpidine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Sophocarpidine in various end use industries. The expanding demands from the Pharmaceuticals, Pesticides and Others,, are propelling Sophocarpidine market. High Purity, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Low Purity segment is estimated at % CAGR for the next seven-year period.
Sophora flavescens Aiton is mainly distributed in Cina, India, Japan, North Korea, Siberia, Russia.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Sophocarpidine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Sophocarpidine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Sophocarpidine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Sophocarpidine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Sophocarpidine covered in this report include Fujie Pharmaceutical, QHL Pharma, Select Botanical, Indena, TIANSHAN Pharmaceuticals, Selco Wirkstoffe Vertriebs GmbH, Jiangsu Tiansheng Pharmaceutical, Tiansheng Pharmaceutical and Hubei Zhongliao Chemical Co., LTD, etc.
The global Sophocarpidine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Fujie Pharmaceutical
QHL Pharma
Select Botanical
Indena
TIANSHAN Pharmaceuticals
Selco Wirkstoffe Vertriebs GmbH
Jiangsu Tiansheng Pharmaceutical
Tiansheng Pharmaceutical
Hubei Zhongliao Chemical Co., LTD
Global Sophocarpidine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Sophocarpidine market, Segment by Type:
High Purity
Low Purity
Global Sophocarpidine market, by Application
Pharmaceuticals
Pesticides
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Sophocarpidine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Sophocarpidine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Sophocarpidine (CAS：519-02-8) is a white acicular crystal or crystalline powder with bitter taste. It is the main raw material for the production of oxymatrine and widely used in the treatment of liver diseases.
The global Sophocarpidine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Sophocarpidine in various end use industries. The expanding demands from the Pharmaceuticals, Pesticides and Others,, are propelling Sophocarpidine market. High Purity, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Low Purity segment is estimated at % CAGR for the next seven-year period.
Sophora flavescens Aiton is mainly distributed in Cina, India, Japan, North Korea, Siberia, Russia.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Sophocarpidine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Sophocarpidine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Sophocarpidine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Sophocarpidine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Sophocarpidine covered in this report include Fujie Pharmaceutical, QHL Pharma, Select Botanical, Indena, TIANSHAN Pharmaceuticals, Selco Wirkstoffe Vertriebs GmbH, Jiangsu Tiansheng Pharmaceutical, Tiansheng Pharmaceutical and Hubei Zhongliao Chemical Co., LTD, etc.
The global Sophocarpidine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Fujie Pharmaceutical
QHL Pharma
Select Botanical
Indena
TIANSHAN Pharmaceuticals
Selco Wirkstoffe Vertriebs GmbH
Jiangsu Tiansheng Pharmaceutical
Tiansheng Pharmaceutical
Hubei Zhongliao Chemical Co., LTD
Global Sophocarpidine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Sophocarpidine market, Segment by Type:
High Purity
Low Purity
Global Sophocarpidine market, by Application
Pharmaceuticals
Pesticides
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Sophocarpidine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Sophocarpidine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Sophocarpidine Market Overview
1.1 Sophocarpidine Product Overview
1.2 Sophocarpidine Market Segment by Type
1.2.1 High Purity
1.2.2 Low Purity
1.3 Global Sophocarpidine Market Size by Type
1.3.1 Global Sophocarpidine Market Size Overview by Type (2018-2029)
1.3.2 Global Sophocarpidine Historic Market Size Review by Type (2018-2023)
1.3.3 Global Sophocarpidine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Sophocarpidine Sales Breakdown by Type (2018-2023)
1.4.2 Europe Sophocarpidine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Sophocarpidine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Sophocarpidine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Sophocarpidine Sales Breakdown by Type (2018-2023)
2 Global Sophocarpidine Market Competition by Company
2.1 Global Top Players by Sophocarpidine Sales (2018-2023)
2.2 Global Top Players by Sophocarpidine Revenue (2018-2023)
2.3 Global Top Players by Sophocarpidine Price (2018-2023)
2.4 Global Top Manufacturers Sophocarpidine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Sophocarpidine Market Competitive Situation and Trends
2.5.1 Sophocarpidine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Sophocarpidine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sophocarpidine as of 2022)
2.7 Date of Key Manufacturers Enter into Sophocarpidine Market
2.8 Key Manufacturers Sophocarpidine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Sophocarpidine Status and Outlook by Region
3.1 Global Sophocarpidine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Sophocarpidine Historic Market Size by Region
3.2.1 Global Sophocarpidine Sales in Volume by Region (2018-2023)
3.2.2 Global Sophocarpidine Sales in Value by Region (2018-2023)
3.2.3 Global Sophocarpidine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Sophocarpidine Forecasted Market Size by Region
3.3.1 Global Sophocarpidine Sales in Volume by Region (2024-2029)
3.3.2 Global Sophocarpidine Sales in Value by Region (2024-2029)
3.3.3 Global Sophocarpidine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Sophocarpidine by Application
4.1 Sophocarpidine Market Segment by Application
4.1.1 Pharmaceuticals
4.1.2 Pesticides
4.1.3 Others
4.2 Global Sophocarpidine Market Size by Application
4.2.1 Global Sophocarpidine Market Size Overview by Application (2018-2029)
4.2.2 Global Sophocarpidine Historic Market Size Review by Application (2018-2023)
4.2.3 Global Sophocarpidine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Sophocarpidine Sales Breakdown by Application (2018-2023)
4.3.2 Europe Sophocarpidine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Sophocarpidine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Sophocarpidine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Sophocarpidine Sales Breakdown by Application (2018-2023)
5 North America Sophocarpidine by Country
5.1 North America Sophocarpidine Historic Market Size by Country
5.1.1 North America Sophocarpidine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Sophocarpidine Sales in Volume by Country (2018-2023)
5.1.3 North America Sophocarpidine Sales in Value by Country (2018-2023)
5.2 North America Sophocarpidine Forecasted Market Size by Country
5.2.1 North America Sophocarpidine Sales in Volume by Country (2024-2029)
5.2.2 North America Sophocarpidine Sales in Value by Country (2024-2029)
6 Europe Sophocarpidine by Country
6.1 Europe Sophocarpidine Historic Market Size by Country
6.1.1 Europe Sophocarpidine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Sophocarpidine Sales in Volume by Country (2018-2023)
6.1.3 Europe Sophocarpidine Sales in Value by Country (2018-2023)
6.2 Europe Sophocarpidine Forecasted Market Size by Country
6.2.1 Europe Sophocarpidine Sales in Volume by Country (2024-2029)
6.2.2 Europe Sophocarpidine Sales in Value by Country (2024-2029)
7 Asia-Pacific Sophocarpidine by Region
7.1 Asia-Pacific Sophocarpidine Historic Market Size by Region
7.1.1 Asia-Pacific Sophocarpidine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Sophocarpidine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Sophocarpidine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Sophocarpidine Forecasted Market Size by Region
7.2.1 Asia-Pacific Sophocarpidine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Sophocarpidine Sales in Value by Region (2024-2029)
8 Latin America Sophocarpidine by Country
8.1 Latin America Sophocarpidine Historic Market Size by Country
8.1.1 Latin America Sophocarpidine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Sophocarpidine Sales in Volume by Country (2018-2023)
8.1.3 Latin America Sophocarpidine Sales in Value by Country (2018-2023)
8.2 Latin America Sophocarpidine Forecasted Market Size by Country
8.2.1 Latin America Sophocarpidine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Sophocarpidine Sales in Value by Country (2024-2029)
9 Middle East and Africa Sophocarpidine by Country
9.1 Middle East and Africa Sophocarpidine Historic Market Size by Country
9.1.1 Middle East and Africa Sophocarpidine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Sophocarpidine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Sophocarpidine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Sophocarpidine Forecasted Market Size by Country
9.2.1 Middle East and Africa Sophocarpidine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Sophocarpidine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Fujie Pharmaceutical
10.1.1 Fujie Pharmaceutical Company Information
10.1.2 Fujie Pharmaceutical Introduction and Business Overview
10.1.3 Fujie Pharmaceutical Sophocarpidine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Fujie Pharmaceutical Sophocarpidine Products Offered
10.1.5 Fujie Pharmaceutical Recent Development
10.2 QHL Pharma
10.2.1 QHL Pharma Company Information
10.2.2 QHL Pharma Introduction and Business Overview
10.2.3 QHL Pharma Sophocarpidine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 QHL Pharma Sophocarpidine Products Offered
10.2.5 QHL Pharma Recent Development
10.3 Select Botanical
10.3.1 Select Botanical Company Information
10.3.2 Select Botanical Introduction and Business Overview
10.3.3 Select Botanical Sophocarpidine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Select Botanical Sophocarpidine Products Offered
10.3.5 Select Botanical Recent Development
10.4 Indena
10.4.1 Indena Company Information
10.4.2 Indena Introduction and Business Overview
10.4.3 Indena Sophocarpidine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Indena Sophocarpidine Products Offered
10.4.5 Indena Recent Development
10.5 TIANSHAN Pharmaceuticals
10.5.1 TIANSHAN Pharmaceuticals Company Information
10.5.2 TIANSHAN Pharmaceuticals Introduction and Business Overview
10.5.3 TIANSHAN Pharmaceuticals Sophocarpidine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 TIANSHAN Pharmaceuticals Sophocarpidine Products Offered
10.5.5 TIANSHAN Pharmaceuticals Recent Development
10.6 Selco Wirkstoffe Vertriebs GmbH
10.6.1 Selco Wirkstoffe Vertriebs GmbH Company Information
10.6.2 Selco Wirkstoffe Vertriebs GmbH Introduction and Business Overview
10.6.3 Selco Wirkstoffe Vertriebs GmbH Sophocarpidine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Selco Wirkstoffe Vertriebs GmbH Sophocarpidine Products Offered
10.6.5 Selco Wirkstoffe Vertriebs GmbH Recent Development
10.7 Jiangsu Tiansheng Pharmaceutical
10.7.1 Jiangsu Tiansheng Pharmaceutical Company Information
10.7.2 Jiangsu Tiansheng Pharmaceutical Introduction and Business Overview
10.7.3 Jiangsu Tiansheng Pharmaceutical Sophocarpidine Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Jiangsu Tiansheng Pharmaceutical Sophocarpidine Products Offered
10.7.5 Jiangsu Tiansheng Pharmaceutical Recent Development
10.8 Tiansheng Pharmaceutical
10.8.1 Tiansheng Pharmaceutical Company Information
10.8.2 Tiansheng Pharmaceutical Introduction and Business Overview
10.8.3 Tiansheng Pharmaceutical Sophocarpidine Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Tiansheng Pharmaceutical Sophocarpidine Products Offered
10.8.5 Tiansheng Pharmaceutical Recent Development
10.9 Hubei Zhongliao Chemical Co., LTD
10.9.1 Hubei Zhongliao Chemical Co., LTD Company Information
10.9.2 Hubei Zhongliao Chemical Co., LTD Introduction and Business Overview
10.9.3 Hubei Zhongliao Chemical Co., LTD Sophocarpidine Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Hubei Zhongliao Chemical Co., LTD Sophocarpidine Products Offered
10.9.5 Hubei Zhongliao Chemical Co., LTD Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Sophocarpidine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Sophocarpidine Industrial Chain Analysis
11.4 Sophocarpidine Market Dynamics
11.4.1 Sophocarpidine Industry Trends
11.4.2 Sophocarpidine Market Drivers
11.4.3 Sophocarpidine Market Challenges
11.4.4 Sophocarpidine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Sophocarpidine Distributors
12.3 Sophocarpidine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
